Zeus Capital acted as Financial Adviser to Connex Solutions in the £9.1m share sale to Belerion Capital in the Manchester based technology firm. The multimillion-pound transaction fully exits three founding ...

Allergy Therapeutics Plc (LON:AGY) is the topic of conversation with Dr Gary Waanders Director of Healthcare Research at Zeus Capital. Since Allergy Therapeutics announced today that it has obtained approval ...

Oncimmune Holdings Plc (LON:ONC) is the topic of conversation when Dr Gary Waanders the Director of Healthcare Research at Zeus Capital caught up with DirectorsTalk. Gary talks us through the ...

Ceres Power Holdings plc (LON:CWR) CEO Phil Caldwell chats with DirectorsTalk about it’s latest trading update. Phil talks about the last 6 months, opportunities for the company, the effects of ...

Allergy Therapeutics Plc (LON:AGY) is the topic of conversation when DirectorsTalk caught up with Dr Gary Waanders the Director of Healthcare Research at Zeus Capital. Gary explains whats driven growth ...

Motif Bio Plc (LON:MTFB) is the topic of conversation when DirectorsTalk caught up with Dr Gary Waanders the Director of Healthcare Research at Zeus Capital. Gary covers the highlights for ...

City of London Investment Group Plc (LON:CLIG) is the topic of conversation with Robin Savage, research director at Zeus Capital. Robin explains why a 61% increase in its profit before ...

Elegant Hotels Group Plc (LON:EHG) is the topic of discussion with Mike Allen, head of research at Zeus Capital. Mike explains his take on the 2016 results, talks about key ...

C4X Discovery Holdings Plc (LON:C4XD) is the topic of discussion with Dr Gary Waanders, Healthcare Research Director at Zeus Capital. Gary, runs through the important highlights from the latest results ...

Mortgage Advice Bureau (Holdings) plc (LON:MAB1) is the topic of conversation when Zeus Capital research director caught up with DirectorsTalk. Robin explains how material is this investment of a joint ...